nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.419	1	CiPCiCtD
Fluocinolone Acetonide—NR3C1—prostate cancer	0.139	1	CbGaD
Fluocinolone Acetonide—PLA2G4A—Epirubicin—prostate cancer	0.107	0.776	CbGbCtD
Fluocinolone Acetonide—NR3C1—Prednisone—prostate cancer	0.0309	0.224	CbGbCtD
Fluocinolone Acetonide—Fluocortolone—Prednisone—prostate cancer	0.0107	0.0563	CrCrCtD
Fluocinolone Acetonide—Alclometasone—Prednisone—prostate cancer	0.0104	0.0547	CrCrCtD
Fluocinolone Acetonide—Amcinonide—Prednisone—prostate cancer	0.0102	0.0533	CrCrCtD
Fluocinolone Acetonide—Budesonide—Prednisone—prostate cancer	0.0102	0.0533	CrCrCtD
Fluocinolone Acetonide—Clobetasol propionate—Prednisone—prostate cancer	0.0099	0.0519	CrCrCtD
Fluocinolone Acetonide—Flunisolide—Prednisone—prostate cancer	0.0099	0.0519	CrCrCtD
Fluocinolone Acetonide—Fludrocortisone—Prednisone—prostate cancer	0.0099	0.0519	CrCrCtD
Fluocinolone Acetonide—Diflorasone—Prednisone—prostate cancer	0.0099	0.0519	CrCrCtD
Fluocinolone Acetonide—Desonide—Prednisone—prostate cancer	0.0099	0.0519	CrCrCtD
Fluocinolone Acetonide—Paramethasone—Prednisone—prostate cancer	0.00965	0.0506	CrCrCtD
Fluocinolone Acetonide—Desoximetasone—Prednisone—prostate cancer	0.00941	0.0494	CrCrCtD
Fluocinolone Acetonide—Fluprednidene Acetate—Prednisone—prostate cancer	0.00919	0.0482	CrCrCtD
Fluocinolone Acetonide—Triamcinolone—Prednisone—prostate cancer	0.00919	0.0482	CrCrCtD
Fluocinolone Acetonide—Fluorometholone—Prednisone—prostate cancer	0.00919	0.0482	CrCrCtD
Fluocinolone Acetonide—Mometasone—Prednisone—prostate cancer	0.00919	0.0482	CrCrCtD
Fluocinolone Acetonide—Dexamethasone—Prednisone—prostate cancer	0.00898	0.0471	CrCrCtD
Fluocinolone Acetonide—Betamethasone—Prednisone—prostate cancer	0.00898	0.0471	CrCrCtD
Fluocinolone Acetonide—Rimexolone—Prednisone—prostate cancer	0.00898	0.0471	CrCrCtD
Fluocinolone Acetonide—Methylprednisolone—Prednisone—prostate cancer	0.00859	0.045	CrCrCtD
Fluocinolone Acetonide—Prednisolone—Prednisone—prostate cancer	0.00841	0.0441	CrCrCtD
Fluocinolone Acetonide—NR3C1—urine—prostate cancer	0.00155	0.133	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—prostate gland—prostate cancer	0.00127	0.109	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—seminal vesicle—prostate cancer	0.00108	0.0924	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—renal system—prostate cancer	0.000868	0.0745	CbGeAlD
Fluocinolone Acetonide—SERPINA6—renal system—prostate cancer	0.000864	0.0742	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—urethra—prostate cancer	0.000852	0.0732	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—bone marrow—prostate cancer	0.000656	0.0563	CbGeAlD
Fluocinolone Acetonide—SERPINA6—bone marrow—prostate cancer	0.000653	0.0561	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—testis—prostate cancer	0.000561	0.0481	CbGeAlD
Fluocinolone Acetonide—NR3C1—prostate gland—prostate cancer	0.000555	0.0477	CbGeAlD
Fluocinolone Acetonide—NR3C1—seminal vesicle—prostate cancer	0.00047	0.0403	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.000413	0.262	CbGdCrCtD
Fluocinolone Acetonide—NR3C1—epithelium—prostate cancer	0.000408	0.035	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—lymph node—prostate cancer	0.000406	0.0349	CbGeAlD
Fluocinolone Acetonide—NR3C1—renal system—prostate cancer	0.000378	0.0325	CbGeAlD
Fluocinolone Acetonide—NR3C1—urethra—prostate cancer	0.000372	0.0319	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Estradiol—Estramustine—prostate cancer	0.000351	0.223	CbGdCrCtD
Fluocinolone Acetonide—NR3C1—bone marrow—prostate cancer	0.000286	0.0246	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—Estradiol—Estrone—prostate cancer	0.000279	0.177	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Estradiol—Conjugated Estrogens—prostate cancer	0.000245	0.156	CbGdCrCtD
Fluocinolone Acetonide—NR3C1—testis—prostate cancer	0.000245	0.021	CbGeAlD
Fluocinolone Acetonide—Amcinonide—ANXA1—prostate cancer	0.000219	0.09	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Estradiol—Ethinyl Estradiol—prostate cancer	0.000206	0.131	CbGdCrCtD
Fluocinolone Acetonide—NR3C1—lymph node—prostate cancer	0.000177	0.0152	CbGeAlD
Fluocinolone Acetonide—Dexamethasone—CYP3A43—prostate cancer	8.71e-05	0.0358	CrCbGaD
Fluocinolone Acetonide—Difluprednate—NR3C1—prostate cancer	7.36e-05	0.0302	CrCbGaD
Fluocinolone Acetonide—Clocortolone—NR3C1—prostate cancer	7.14e-05	0.0293	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—ANXA1—prostate cancer	6.88e-05	0.0283	CrCbGaD
Fluocinolone Acetonide—Diflorasone—NR3C1—prostate cancer	6.75e-05	0.0277	CrCbGaD
Fluocinolone Acetonide—Desonide—NR3C1—prostate cancer	6.75e-05	0.0277	CrCbGaD
Fluocinolone Acetonide—Desoximetasone—NR3C1—prostate cancer	6.59e-05	0.0271	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—AR—prostate cancer	6.42e-05	0.0264	CrCbGaD
Fluocinolone Acetonide—Beclomethasone—CYP3A5—prostate cancer	6.16e-05	0.0253	CrCbGaD
Fluocinolone Acetonide—Flurandrenolide—NR3C1—prostate cancer	5.77e-05	0.0237	CrCbGaD
Fluocinolone Acetonide—Flumethasone Pivalate—NR3C1—prostate cancer	5.67e-05	0.0233	CrCbGaD
Fluocinolone Acetonide—Halobetasol Propionate—NR3C1—prostate cancer	5.58e-05	0.0229	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Estradiol—prostate cancer	5.3e-05	0.000817	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Doxorubicin—prostate cancer	5.29e-05	0.000815	CcSEcCtD
Fluocinolone Acetonide—Amcinonide—NR3C1—prostate cancer	5.19e-05	0.0213	CrCbGaD
Fluocinolone Acetonide—Budesonide—NR3C1—prostate cancer	5.19e-05	0.0213	CrCbGaD
Fluocinolone Acetonide—Eye disorder—Etoposide—prostate cancer	5.18e-05	0.000799	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Capecitabine—prostate cancer	5.18e-05	0.000798	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Ethinyl Estradiol—prostate cancer	5.15e-05	0.000794	CcSEcCtD
Fluocinolone Acetonide—Infestation—Docetaxel—prostate cancer	5.13e-05	0.000791	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Docetaxel—prostate cancer	5.13e-05	0.000791	CcSEcCtD
Fluocinolone Acetonide—Fluticasone furoate—NR3C1—prostate cancer	5.09e-05	0.0209	CrCbGaD
Fluocinolone Acetonide—Oedema—Estradiol—prostate cancer	5.08e-05	0.000783	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Goserelin—prostate cancer	5.07e-05	0.000781	CcSEcCtD
Fluocinolone Acetonide—Cough—Mitoxantrone—prostate cancer	5.06e-05	0.00078	CcSEcCtD
Fluocinolone Acetonide—Infection—Estradiol—prostate cancer	5.05e-05	0.000778	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Conjugated Estrogens—prostate cancer	5.02e-05	0.000774	CcSEcCtD
Fluocinolone Acetonide—Eczema—Epirubicin—prostate cancer	5e-05	0.00077	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Etoposide—prostate cancer	4.99e-05	0.00077	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Estradiol—prostate cancer	4.98e-05	0.000768	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Epirubicin—prostate cancer	4.97e-05	0.000767	CcSEcCtD
Fluocinolone Acetonide—Infestation—Capecitabine—prostate cancer	4.97e-05	0.000766	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Capecitabine—prostate cancer	4.97e-05	0.000766	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Ethinyl Estradiol—prostate cancer	4.95e-05	0.000763	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Mitoxantrone—prostate cancer	4.94e-05	0.000761	CcSEcCtD
Fluocinolone Acetonide—Mometasone—NR3C1—prostate cancer	4.93e-05	0.0203	CrCbGaD
Fluocinolone Acetonide—Rash—Ethinyl Estradiol—prostate cancer	4.91e-05	0.000757	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Ethinyl Estradiol—prostate cancer	4.9e-05	0.000756	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Etoposide—prostate cancer	4.9e-05	0.000755	CcSEcCtD
Fluocinolone Acetonide—Headache—Ethinyl Estradiol—prostate cancer	4.88e-05	0.000752	CcSEcCtD
Fluocinolone Acetonide—Rimexolone—NR3C1—prostate cancer	4.88e-05	0.02	CrCbGaD
Fluocinolone Acetonide—Oedema—Mitoxantrone—prostate cancer	4.73e-05	0.00073	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Etoposide—prostate cancer	4.72e-05	0.000728	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Goserelin—prostate cancer	4.72e-05	0.000728	CcSEcCtD
Fluocinolone Acetonide—Infection—Mitoxantrone—prostate cancer	4.7e-05	0.000725	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Conjugated Estrogens—prostate cancer	4.68e-05	0.000721	CcSEcCtD
Fluocinolone Acetonide—Back pain—Etoposide—prostate cancer	4.67e-05	0.00072	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Estradiol—prostate cancer	4.63e-05	0.000714	CcSEcCtD
Fluocinolone Acetonide—Nausea—Ethinyl Estradiol—prostate cancer	4.63e-05	0.000713	CcSEcCtD
Fluocinolone Acetonide—Eczema—Doxorubicin—prostate cancer	4.62e-05	0.000713	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Docetaxel—prostate cancer	4.62e-05	0.000712	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Doxorubicin—prostate cancer	4.6e-05	0.00071	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Epirubicin—prostate cancer	4.6e-05	0.00071	CcSEcCtD
Fluocinolone Acetonide—Beclomethasone—NR3C1—prostate cancer	4.6e-05	0.0189	CrCbGaD
Fluocinolone Acetonide—Fluocinonide—NR3C1—prostate cancer	4.6e-05	0.0189	CrCbGaD
Fluocinolone Acetonide—Pruritus—Goserelin—prostate cancer	4.53e-05	0.000699	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Docetaxel—prostate cancer	4.53e-05	0.000698	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Conjugated Estrogens—prostate cancer	4.49e-05	0.000692	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Epirubicin—prostate cancer	4.49e-05	0.000692	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Epirubicin—prostate cancer	4.49e-05	0.000692	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Capecitabine—prostate cancer	4.47e-05	0.000689	CcSEcCtD
Fluocinolone Acetonide—Alclometasone—NR3C1—prostate cancer	4.47e-05	0.0184	CrCbGaD
Fluocinolone Acetonide—Visual impairment—Docetaxel—prostate cancer	4.44e-05	0.000684	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Estradiol—prostate cancer	4.39e-05	0.000676	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Goserelin—prostate cancer	4.38e-05	0.000676	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Capecitabine—prostate cancer	4.38e-05	0.000676	CcSEcCtD
Fluocinolone Acetonide—Flunisolide—NR3C1—prostate cancer	4.35e-05	0.0179	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—NR3C1—prostate cancer	4.35e-05	0.0179	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—NR3C1—prostate cancer	4.35e-05	0.0179	CrCbGaD
Fluocinolone Acetonide—Pain—Estradiol—prostate cancer	4.34e-05	0.00067	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Conjugated Estrogens—prostate cancer	4.34e-05	0.00067	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Etoposide—prostate cancer	4.33e-05	0.000668	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	4.31e-05	0.000665	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Docetaxel—prostate cancer	4.3e-05	0.000664	CcSEcCtD
Fluocinolone Acetonide—Paramethasone—NR3C1—prostate cancer	4.3e-05	0.0176	CrCbGaD
Fluocinolone Acetonide—Visual impairment—Capecitabine—prostate cancer	4.3e-05	0.000663	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Doxorubicin—prostate cancer	4.26e-05	0.000656	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Goserelin—prostate cancer	4.24e-05	0.000653	CcSEcCtD
Fluocinolone Acetonide—Cough—Etoposide—prostate cancer	4.21e-05	0.000649	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Conjugated Estrogens—prostate cancer	4.2e-05	0.000647	CcSEcCtD
Fluocinolone Acetonide—Fluorometholone—NR3C1—prostate cancer	4.19e-05	0.0172	CrCbGaD
Fluocinolone Acetonide—Eye disorder—Capecitabine—prostate cancer	4.17e-05	0.000643	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Doxorubicin—prostate cancer	4.15e-05	0.000641	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Doxorubicin—prostate cancer	4.15e-05	0.000641	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Docetaxel—prostate cancer	4.15e-05	0.00064	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—CYP3A5—prostate cancer	4.09e-05	0.0168	CrCbGaD
Fluocinolone Acetonide—Vomiting—Goserelin—prostate cancer	4.07e-05	0.000628	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Docetaxel—prostate cancer	4.07e-05	0.000628	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—NR3C1—prostate cancer	4.06e-05	0.0167	CrCbGaD
Fluocinolone Acetonide—Pain—Mitoxantrone—prostate cancer	4.05e-05	0.000624	CcSEcCtD
Fluocinolone Acetonide—Rash—Goserelin—prostate cancer	4.04e-05	0.000623	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Goserelin—prostate cancer	4.04e-05	0.000622	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Conjugated Estrogens—prostate cancer	4.04e-05	0.000622	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Docetaxel—prostate cancer	4.03e-05	0.000622	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Betamethasone—Prednisone—prostate cancer	4.03e-05	0.0256	CbGdCrCtD
Fluocinolone Acetonide—PLA2G4A—Dexamethasone—Prednisone—prostate cancer	4.03e-05	0.0256	CbGdCrCtD
Fluocinolone Acetonide—Mediastinal disorder—Capecitabine—prostate cancer	4.02e-05	0.00062	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Estradiol—prostate cancer	4.02e-05	0.000619	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Epirubicin—prostate cancer	4.02e-05	0.000619	CcSEcCtD
Fluocinolone Acetonide—Headache—Goserelin—prostate cancer	4.01e-05	0.000619	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Docetaxel—prostate cancer	4.01e-05	0.000618	CcSEcCtD
Fluocinolone Acetonide—Erythema—Docetaxel—prostate cancer	4.01e-05	0.000618	CcSEcCtD
Fluocinolone Acetonide—Rash—Conjugated Estrogens—prostate cancer	4e-05	0.000617	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Conjugated Estrogens—prostate cancer	4e-05	0.000617	CcSEcCtD
Fluocinolone Acetonide—Headache—Conjugated Estrogens—prostate cancer	3.98e-05	0.000613	CcSEcCtD
Fluocinolone Acetonide—Clobetasol propionate—CYP1A1—prostate cancer	3.95e-05	0.0162	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—CYP17A1—prostate cancer	3.95e-05	0.0162	CrCbGaD
Fluocinolone Acetonide—Alopecia—Capecitabine—prostate cancer	3.94e-05	0.000608	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Docetaxel—prostate cancer	3.93e-05	0.000605	CcSEcCtD
Fluocinolone Acetonide—Infection—Etoposide—prostate cancer	3.91e-05	0.000603	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Capecitabine—prostate cancer	3.91e-05	0.000602	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Prednisone—prostate cancer	3.9e-05	0.000602	CcSEcCtD
Fluocinolone Acetonide—Erythema—Capecitabine—prostate cancer	3.88e-05	0.000599	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Capecitabine—prostate cancer	3.88e-05	0.000599	CcSEcCtD
Fluocinolone Acetonide—Influenza—Epirubicin—prostate cancer	3.88e-05	0.000598	CcSEcCtD
Fluocinolone Acetonide—Back pain—Docetaxel—prostate cancer	3.88e-05	0.000598	CcSEcCtD
Fluocinolone Acetonide—Nausea—Goserelin—prostate cancer	3.81e-05	0.000587	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Capecitabine—prostate cancer	3.8e-05	0.000586	CcSEcCtD
Fluocinolone Acetonide—Nausea—Conjugated Estrogens—prostate cancer	3.77e-05	0.000581	CcSEcCtD
Fluocinolone Acetonide—Back pain—Capecitabine—prostate cancer	3.75e-05	0.000579	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Estradiol—prostate cancer	3.74e-05	0.000577	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Mitoxantrone—prostate cancer	3.74e-05	0.000577	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Doxorubicin—prostate cancer	3.72e-05	0.000573	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Prednisone—prostate cancer	3.71e-05	0.000572	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—CYP2A6—prostate cancer	3.71e-05	0.0152	CrCbGaD
Fluocinolone Acetonide—Vision blurred—Capecitabine—prostate cancer	3.66e-05	0.000564	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Epirubicin—prostate cancer	3.61e-05	0.000556	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Estradiol—prostate cancer	3.59e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Influenza—Doxorubicin—prostate cancer	3.59e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Prednisone—prostate cancer	3.51e-05	0.000541	CcSEcCtD
Fluocinolone Acetonide—Cough—Docetaxel—prostate cancer	3.5e-05	0.000539	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Capecitabine—prostate cancer	3.49e-05	0.000538	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Mitoxantrone—prostate cancer	3.49e-05	0.000538	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Prednisone—prostate cancer	3.48e-05	0.000537	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Estradiol—prostate cancer	3.48e-05	0.000536	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Epirubicin—prostate cancer	3.46e-05	0.000534	CcSEcCtD
Fluocinolone Acetonide—Infestation—Epirubicin—prostate cancer	3.46e-05	0.000534	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Prednisone—prostate cancer	3.46e-05	0.000533	CcSEcCtD
Fluocinolone Acetonide—Erythema—Prednisone—prostate cancer	3.46e-05	0.000533	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—CYP19A1—prostate cancer	3.46e-05	0.0142	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—NR3C1—prostate cancer	3.42e-05	0.014	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Docetaxel—prostate cancer	3.41e-05	0.000526	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Etoposide—prostate cancer	3.4e-05	0.000524	CcSEcCtD
Fluocinolone Acetonide—Cough—Capecitabine—prostate cancer	3.39e-05	0.000522	CcSEcCtD
Fluocinolone Acetonide—Pain—Etoposide—prostate cancer	3.37e-05	0.000519	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Estradiol—prostate cancer	3.36e-05	0.000518	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Doxorubicin—prostate cancer	3.34e-05	0.000515	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Capecitabine—prostate cancer	3.3e-05	0.00051	CcSEcCtD
Fluocinolone Acetonide—Oedema—Docetaxel—prostate cancer	3.27e-05	0.000505	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Prednisone—prostate cancer	3.26e-05	0.000502	CcSEcCtD
Fluocinolone Acetonide—Infection—Docetaxel—prostate cancer	3.25e-05	0.000501	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Epirubicin—prostate cancer	3.25e-05	0.000501	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Mitoxantrone—prostate cancer	3.24e-05	0.000499	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Estradiol—prostate cancer	3.23e-05	0.000498	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Docetaxel—prostate cancer	3.21e-05	0.000495	CcSEcCtD
Fluocinolone Acetonide—Rash—Estradiol—prostate cancer	3.2e-05	0.000494	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Doxorubicin—prostate cancer	3.2e-05	0.000494	CcSEcCtD
Fluocinolone Acetonide—Infestation—Doxorubicin—prostate cancer	3.2e-05	0.000494	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Estradiol—prostate cancer	3.2e-05	0.000493	CcSEcCtD
Fluocinolone Acetonide—Headache—Estradiol—prostate cancer	3.18e-05	0.000491	CcSEcCtD
Fluocinolone Acetonide—Oedema—Capecitabine—prostate cancer	3.17e-05	0.000489	CcSEcCtD
Fluocinolone Acetonide—Infection—Capecitabine—prostate cancer	3.15e-05	0.000485	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Epirubicin—prostate cancer	3.11e-05	0.00048	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Etoposide—prostate cancer	3.11e-05	0.00048	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Capecitabine—prostate cancer	3.11e-05	0.000479	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Prednisone—prostate cancer	3.11e-05	0.000479	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C1—prostate cancer	3.06e-05	0.0126	CrCbGaD
Fluocinolone Acetonide—Connective tissue disorder—Epirubicin—prostate cancer	3.05e-05	0.000471	CcSEcCtD
Fluocinolone Acetonide—Nausea—Estradiol—prostate cancer	3.02e-05	0.000465	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Mitoxantrone—prostate cancer	3.01e-05	0.000464	CcSEcCtD
Fluocinolone Acetonide—Budesonide—CYP3A4—prostate cancer	3.01e-05	0.0123	CrCbGaD
Fluocinolone Acetonide—Sinusitis—Doxorubicin—prostate cancer	3e-05	0.000463	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Epirubicin—prostate cancer	2.99e-05	0.000462	CcSEcCtD
Fluocinolone Acetonide—Rash—Mitoxantrone—prostate cancer	2.98e-05	0.00046	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Mitoxantrone—prostate cancer	2.98e-05	0.00046	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.98e-05	0.00046	CcSEcCtD
Fluocinolone Acetonide—Headache—Mitoxantrone—prostate cancer	2.97e-05	0.000457	CcSEcCtD
Fluocinolone Acetonide—Fluticasone furoate—CYP3A4—prostate cancer	2.95e-05	0.0121	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Prednisone—prostate cancer	2.94e-05	0.000454	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Epirubicin—prostate cancer	2.9e-05	0.000448	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Etoposide—prostate cancer	2.9e-05	0.000447	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.89e-05	0.000445	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Doxorubicin—prostate cancer	2.88e-05	0.000444	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—NR3C1—prostate cancer	2.86e-05	0.0117	CrCbGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Docetaxel—prostate cancer	2.82e-05	0.000436	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Doxorubicin—prostate cancer	2.82e-05	0.000436	CcSEcCtD
Fluocinolone Acetonide—Oedema—Prednisone—prostate cancer	2.82e-05	0.000435	CcSEcCtD
Fluocinolone Acetonide—Nausea—Mitoxantrone—prostate cancer	2.81e-05	0.000434	CcSEcCtD
Fluocinolone Acetonide—Infection—Prednisone—prostate cancer	2.8e-05	0.000432	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—NR3C1—prostate cancer	2.8e-05	0.0115	CrCbGaD
Fluocinolone Acetonide—Mediastinal disorder—Epirubicin—prostate cancer	2.8e-05	0.000432	CcSEcCtD
Fluocinolone Acetonide—Pain—Docetaxel—prostate cancer	2.8e-05	0.000431	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Etoposide—prostate cancer	2.79e-05	0.00043	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Doxorubicin—prostate cancer	2.77e-05	0.000427	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Prednisone—prostate cancer	2.77e-05	0.000427	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Epirubicin—prostate cancer	2.75e-05	0.000423	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP1B1—prostate cancer	2.74e-05	0.0113	CrCbGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Capecitabine—prostate cancer	2.74e-05	0.000422	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Epirubicin—prostate cancer	2.72e-05	0.00042	CcSEcCtD
Fluocinolone Acetonide—Pain—Capecitabine—prostate cancer	2.71e-05	0.000418	CcSEcCtD
Fluocinolone Acetonide—Erythema—Epirubicin—prostate cancer	2.7e-05	0.000417	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Epirubicin—prostate cancer	2.7e-05	0.000417	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Etoposide—prostate cancer	2.69e-05	0.000415	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Doxorubicin—prostate cancer	2.69e-05	0.000414	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Epirubicin—prostate cancer	2.65e-05	0.000408	CcSEcCtD
Fluocinolone Acetonide—Back pain—Epirubicin—prostate cancer	2.62e-05	0.000403	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Etoposide—prostate cancer	2.6e-05	0.000401	CcSEcCtD
Fluocinolone Acetonide—Alclometasone—CYP3A4—prostate cancer	2.59e-05	0.0106	CrCbGaD
Fluocinolone Acetonide—Mediastinal disorder—Doxorubicin—prostate cancer	2.59e-05	0.000399	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Docetaxel—prostate cancer	2.59e-05	0.000399	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Prednisone—prostate cancer	2.57e-05	0.000396	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Epirubicin—prostate cancer	2.55e-05	0.000393	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Doxorubicin—prostate cancer	2.54e-05	0.000392	CcSEcCtD
Fluocinolone Acetonide—Flunisolide—CYP3A4—prostate cancer	2.52e-05	0.0104	CrCbGaD
Fluocinolone Acetonide—Mental disorder—Doxorubicin—prostate cancer	2.52e-05	0.000388	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Capecitabine—prostate cancer	2.5e-05	0.000386	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Etoposide—prostate cancer	2.5e-05	0.000386	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Doxorubicin—prostate cancer	2.5e-05	0.000386	CcSEcCtD
Fluocinolone Acetonide—Erythema—Doxorubicin—prostate cancer	2.5e-05	0.000386	CcSEcCtD
Fluocinolone Acetonide—Paramethasone—CYP3A4—prostate cancer	2.49e-05	0.0102	CrCbGaD
Fluocinolone Acetonide—Rash—Etoposide—prostate cancer	2.48e-05	0.000383	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Etoposide—prostate cancer	2.48e-05	0.000382	CcSEcCtD
Fluocinolone Acetonide—Headache—Etoposide—prostate cancer	2.47e-05	0.00038	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Doxorubicin—prostate cancer	2.45e-05	0.000378	CcSEcCtD
Fluocinolone Acetonide—Fluorometholone—CYP3A4—prostate cancer	2.43e-05	0.00999	CrCbGaD
Fluocinolone Acetonide—Vertigo—Epirubicin—prostate cancer	2.43e-05	0.000375	CcSEcCtD
Fluocinolone Acetonide—Back pain—Doxorubicin—prostate cancer	2.42e-05	0.000373	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Docetaxel—prostate cancer	2.41e-05	0.000372	CcSEcCtD
Fluocinolone Acetonide—Cough—Epirubicin—prostate cancer	2.36e-05	0.000364	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Doxorubicin—prostate cancer	2.36e-05	0.000364	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—CYP3A4—prostate cancer	2.35e-05	0.00965	CrCbGaD
Fluocinolone Acetonide—Nausea—Etoposide—prostate cancer	2.34e-05	0.000361	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Capecitabine—prostate cancer	2.33e-05	0.00036	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Docetaxel—prostate cancer	2.32e-05	0.000357	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Epirubicin—prostate cancer	2.3e-05	0.000355	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Doxorubicin—prostate cancer	2.25e-05	0.000347	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Capecitabine—prostate cancer	2.24e-05	0.000346	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Docetaxel—prostate cancer	2.24e-05	0.000345	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Prednisone—prostate cancer	2.23e-05	0.000344	CcSEcCtD
Fluocinolone Acetonide—Oedema—Epirubicin—prostate cancer	2.21e-05	0.00034	CcSEcCtD
Fluocinolone Acetonide—Infection—Epirubicin—prostate cancer	2.19e-05	0.000338	CcSEcCtD
Fluocinolone Acetonide—Cough—Doxorubicin—prostate cancer	2.18e-05	0.000337	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP3A5—prostate cancer	2.18e-05	0.00896	CrCbGaD
Fluocinolone Acetonide—Diarrhoea—Capecitabine—prostate cancer	2.17e-05	0.000334	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Epirubicin—prostate cancer	2.16e-05	0.000334	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Docetaxel—prostate cancer	2.16e-05	0.000334	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Doxorubicin—prostate cancer	2.13e-05	0.000328	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP2A6—prostate cancer	2.11e-05	0.00867	CrCbGaD
Fluocinolone Acetonide—Dizziness—Capecitabine—prostate cancer	2.09e-05	0.000323	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Docetaxel—prostate cancer	2.08e-05	0.000321	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Prednisone—prostate cancer	2.08e-05	0.000321	CcSEcCtD
Fluocinolone Acetonide—Rash—Docetaxel—prostate cancer	2.06e-05	0.000318	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Docetaxel—prostate cancer	2.06e-05	0.000318	CcSEcCtD
Fluocinolone Acetonide—Headache—Docetaxel—prostate cancer	2.05e-05	0.000316	CcSEcCtD
Fluocinolone Acetonide—Oedema—Doxorubicin—prostate cancer	2.04e-05	0.000315	CcSEcCtD
Fluocinolone Acetonide—Infection—Doxorubicin—prostate cancer	2.03e-05	0.000313	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Capecitabine—prostate cancer	2.01e-05	0.000311	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.01e-05	0.00031	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP19A1—prostate cancer	2.01e-05	0.00826	CrCbGaD
Fluocinolone Acetonide—Nervous system disorder—Doxorubicin—prostate cancer	2e-05	0.000309	CcSEcCtD
Fluocinolone Acetonide—Rash—Capecitabine—prostate cancer	2e-05	0.000308	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Prednisone—prostate cancer	2e-05	0.000308	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Capecitabine—prostate cancer	2e-05	0.000308	CcSEcCtD
Fluocinolone Acetonide—Headache—Capecitabine—prostate cancer	1.98e-05	0.000306	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—CYP3A4—prostate cancer	1.98e-05	0.00814	CrCbGaD
Fluocinolone Acetonide—Nausea—Docetaxel—prostate cancer	1.94e-05	0.0003	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—prostate cancer	1.94e-05	0.00797	CrCbGaD
Fluocinolone Acetonide—Diarrhoea—Prednisone—prostate cancer	1.93e-05	0.000298	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Epirubicin—prostate cancer	1.91e-05	0.000294	CcSEcCtD
Fluocinolone Acetonide—Pain—Epirubicin—prostate cancer	1.89e-05	0.000291	CcSEcCtD
Fluocinolone Acetonide—Nausea—Capecitabine—prostate cancer	1.88e-05	0.00029	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Prednisone—prostate cancer	1.87e-05	0.000288	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.86e-05	0.000287	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Prednisone—prostate cancer	1.79e-05	0.000277	CcSEcCtD
Fluocinolone Acetonide—Rash—Prednisone—prostate cancer	1.78e-05	0.000274	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Prednisone—prostate cancer	1.78e-05	0.000274	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—CYP3A4—prostate cancer	1.77e-05	0.00728	CrCbGaD
Fluocinolone Acetonide—Headache—Prednisone—prostate cancer	1.77e-05	0.000273	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.76e-05	0.000272	CcSEcCtD
Fluocinolone Acetonide—Pain—Doxorubicin—prostate cancer	1.75e-05	0.000269	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Epirubicin—prostate cancer	1.74e-05	0.000269	CcSEcCtD
Fluocinolone Acetonide—Nausea—Prednisone—prostate cancer	1.68e-05	0.000258	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—CYP3A4—prostate cancer	1.66e-05	0.00681	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—NR3C1—prostate cancer	1.63e-05	0.00669	CrCbGaD
Fluocinolone Acetonide—Hypersensitivity—Epirubicin—prostate cancer	1.63e-05	0.000251	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—CYP3A4—prostate cancer	1.62e-05	0.00667	CrCbGaD
Fluocinolone Acetonide—Body temperature increased—Doxorubicin—prostate cancer	1.61e-05	0.000249	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PTGS2—prostate cancer	1.59e-05	0.00653	CrCbGaD
Fluocinolone Acetonide—Pruritus—Epirubicin—prostate cancer	1.56e-05	0.000241	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Epirubicin—prostate cancer	1.51e-05	0.000233	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Doxorubicin—prostate cancer	1.5e-05	0.000232	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP2E1—prostate cancer	1.5e-05	0.00616	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—CYP2C19—prostate cancer	1.48e-05	0.0061	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—CYP1A1—prostate cancer	1.48e-05	0.00608	CrCbGaD
Fluocinolone Acetonide—Dizziness—Epirubicin—prostate cancer	1.46e-05	0.000225	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Doxorubicin—prostate cancer	1.44e-05	0.000223	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTA4—prostate cancer	1.43e-05	0.000439	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TBXAS1—prostate cancer	1.43e-05	0.000439	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PTHLH—prostate cancer	1.42e-05	0.000438	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.42e-05	0.000436	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.41e-05	0.000433	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.41e-05	0.000432	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.4e-05	0.000431	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Epirubicin—prostate cancer	1.4e-05	0.000216	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Doxorubicin—prostate cancer	1.4e-05	0.000215	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.4e-05	0.000429	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKACB—prostate cancer	1.39e-05	0.000428	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	1.39e-05	0.000428	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Epirubicin—prostate cancer	1.39e-05	0.000215	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTA2—prostate cancer	1.39e-05	0.000428	CbGpPWpGaD
Fluocinolone Acetonide—Dermatitis—Epirubicin—prostate cancer	1.39e-05	0.000214	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.39e-05	0.000427	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.38e-05	0.000425	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Epirubicin—prostate cancer	1.38e-05	0.000213	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF3A—prostate cancer	1.38e-05	0.000423	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.38e-05	0.000423	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SULT1A1—prostate cancer	1.37e-05	0.000422	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCG5—prostate cancer	1.37e-05	0.000422	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PPP3CA—prostate cancer	1.36e-05	0.000417	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Doxorubicin—prostate cancer	1.35e-05	0.000208	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAU—prostate cancer	1.35e-05	0.000415	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTA1—prostate cancer	1.34e-05	0.000413	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ANXA1—prostate cancer	1.34e-05	0.000411	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.33e-05	0.000409	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSD3B2—prostate cancer	1.33e-05	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NAT2—prostate cancer	1.33e-05	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTO1—prostate cancer	1.33e-05	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CAV1—prostate cancer	1.32e-05	0.000405	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Epirubicin—prostate cancer	1.31e-05	0.000202	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PENK—prostate cancer	1.31e-05	0.000401	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.3e-05	0.0004	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Doxorubicin—prostate cancer	1.3e-05	0.0002	CcSEcCtD
Fluocinolone Acetonide—Rash—Doxorubicin—prostate cancer	1.29e-05	0.000199	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Doxorubicin—prostate cancer	1.29e-05	0.000198	CcSEcCtD
Fluocinolone Acetonide—Headache—Doxorubicin—prostate cancer	1.28e-05	0.000197	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	1.28e-05	0.000393	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.28e-05	0.000392	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.27e-05	0.000391	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLCB2—prostate cancer	1.27e-05	0.000391	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2C18—prostate cancer	1.27e-05	0.000391	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LRP2—prostate cancer	1.27e-05	0.000391	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CALCA—prostate cancer	1.25e-05	0.000385	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—P4HB—prostate cancer	1.25e-05	0.000384	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GHR—prostate cancer	1.25e-05	0.000383	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL12—prostate cancer	1.22e-05	0.000376	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.22e-05	0.000376	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC22A1—prostate cancer	1.21e-05	0.000373	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Doxorubicin—prostate cancer	1.21e-05	0.000187	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CG—prostate cancer	1.2e-05	0.000369	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.2e-05	0.000369	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NRP1—prostate cancer	1.19e-05	0.000367	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EGF—prostate cancer	1.19e-05	0.000365	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SULT2A1—prostate cancer	1.18e-05	0.000364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.18e-05	0.000364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MED12—prostate cancer	1.16e-05	0.000358	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT3B—prostate cancer	1.16e-05	0.000356	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNG5—prostate cancer	1.15e-05	0.000355	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPL10—prostate cancer	1.14e-05	0.000349	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCQ—prostate cancer	1.12e-05	0.000343	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	1.11e-05	0.000343	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CREBBP—prostate cancer	1.11e-05	0.000342	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA3—prostate cancer	1.11e-05	0.000342	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VIP—prostate cancer	1.11e-05	0.000341	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNRH1—prostate cancer	1.11e-05	0.000341	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—prostate cancer	1.1e-05	0.000338	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.09e-05	0.000336	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.09e-05	0.000334	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NPPA—prostate cancer	1.08e-05	0.000331	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HIST1H4H—prostate cancer	1.08e-05	0.000331	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPAR1—prostate cancer	1.08e-05	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRP—prostate cancer	1.08e-05	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	1.07e-05	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LRP2—prostate cancer	1.06e-05	0.000327	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLCB2—prostate cancer	1.06e-05	0.000327	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HPGDS—prostate cancer	1.06e-05	0.000326	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MED12—prostate cancer	1.06e-05	0.000325	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CD—prostate cancer	1.06e-05	0.000324	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2C19—prostate cancer	1.05e-05	0.000324	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRB2—prostate cancer	1.05e-05	0.000323	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—prostate cancer	1.04e-05	0.000321	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CX3CL1—prostate cancer	1.04e-05	0.000321	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—P4HB—prostate cancer	1.04e-05	0.000321	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—prostate cancer	1.04e-05	0.00032	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTT1—prostate cancer	1.03e-05	0.000316	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ACHE—prostate cancer	1.03e-05	0.000316	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—VAV3—prostate cancer	1.02e-05	0.000315	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIST1H2BG—prostate cancer	1.02e-05	0.000315	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2A6—prostate cancer	1.02e-05	0.000313	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRB7—prostate cancer	1.02e-05	0.000312	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDE4D—prostate cancer	1.02e-05	0.000312	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.01e-05	0.000311	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	9.99e-06	0.000307	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—prostate cancer	9.97e-06	0.000306	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ITPR1—prostate cancer	9.94e-06	0.000305	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKR1C3—prostate cancer	9.9e-06	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIST1H4H—prostate cancer	9.89e-06	0.000304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PRKACB—prostate cancer	9.85e-06	0.000303	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP17A1—prostate cancer	9.74e-06	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	9.73e-06	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—JAK2—prostate cancer	9.69e-06	0.000298	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNG5—prostate cancer	9.66e-06	0.000297	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.61e-06	0.000295	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—CYP3A4—prostate cancer	9.44e-06	0.00388	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA2—prostate cancer	9.28e-06	0.000285	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—prostate cancer	9.25e-06	0.0038	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CB—prostate cancer	9.2e-06	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	9.01e-06	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPS19—prostate cancer	9.01e-06	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—prostate cancer	8.89e-06	0.000273	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC5A5—prostate cancer	8.86e-06	0.000272	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2E1—prostate cancer	8.65e-06	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—DNMT1—prostate cancer	8.61e-06	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NQO1—prostate cancer	8.55e-06	0.000263	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	8.53e-06	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IL2—prostate cancer	8.45e-06	0.00026	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOA2—prostate cancer	8.45e-06	0.00026	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TH—prostate cancer	8.43e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTHLH—prostate cancer	8.41e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFBR1—prostate cancer	8.41e-06	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.38e-06	0.000257	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP3A4—prostate cancer	8.34e-06	0.000256	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EZH2—prostate cancer	8.34e-06	0.000256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.3e-06	0.000255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKR1C3—prostate cancer	8.28e-06	0.000254	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKACB—prostate cancer	8.23e-06	0.000253	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1B1—prostate cancer	8.2e-06	0.000252	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PARP1—prostate cancer	8.16e-06	0.000251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPP3CA—prostate cancer	8.03e-06	0.000247	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—THBS1—prostate cancer	8.03e-06	0.000247	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	8e-06	0.000246	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GGT1—prostate cancer	7.94e-06	0.000244	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ANXA1—prostate cancer	7.91e-06	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NCOA1—prostate cancer	7.82e-06	0.00024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCZ—prostate cancer	7.76e-06	0.000239	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPA1A—prostate cancer	7.73e-06	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR2—prostate cancer	7.73e-06	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP19A1—prostate cancer	7.71e-06	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EP300—prostate cancer	7.58e-06	0.000233	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PARP1—prostate cancer	7.5e-06	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR4—prostate cancer	7.5e-06	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—RXRA—prostate cancer	7.44e-06	0.000229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CALCA—prostate cancer	7.41e-06	0.000228	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SRC—prostate cancer	7.37e-06	0.000227	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.24e-06	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL12—prostate cancer	7.23e-06	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—prostate cancer	7.18e-06	0.000221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—COMT—prostate cancer	7.17e-06	0.00022	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTP1—prostate cancer	7.13e-06	0.000219	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NCOA1—prostate cancer	7.12e-06	0.000219	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ITPR1—prostate cancer	7.02e-06	0.000216	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.9e-06	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CG—prostate cancer	6.89e-06	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AR—prostate cancer	6.83e-06	0.00021	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP9—prostate cancer	6.81e-06	0.000209	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RXRA—prostate cancer	6.77e-06	0.000208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TYMS—prostate cancer	6.63e-06	0.000204	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCQ—prostate cancer	6.6e-06	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NGFR—prostate cancer	6.6e-06	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—prostate cancer	6.59e-06	0.000203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—prostate cancer	6.56e-06	0.000201	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAP3K7—prostate cancer	6.52e-06	0.0002	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPL—prostate cancer	6.44e-06	0.000198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF10—prostate cancer	6.27e-06	0.000193	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SIRT1—prostate cancer	6.22e-06	0.000191	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1A1—prostate cancer	6.22e-06	0.000191	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRB2—prostate cancer	6.21e-06	0.000191	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ERCC2—prostate cancer	6.16e-06	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—VDR—prostate cancer	6.13e-06	0.000188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KRAS—prostate cancer	6.1e-06	0.000188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAP2K1—prostate cancer	6.1e-06	0.000187	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CD—prostate cancer	6.06e-06	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VAV3—prostate cancer	6.05e-06	0.000186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFBR2—prostate cancer	5.97e-06	0.000183	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITPR1—prostate cancer	5.87e-06	0.00018	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—prostate cancer	5.79e-06	0.000178	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARA—prostate cancer	5.68e-06	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1R—prostate cancer	5.61e-06	0.000172	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ERCC2—prostate cancer	5.61e-06	0.000172	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—prostate cancer	5.61e-06	0.000172	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—JAK2—prostate cancer	5.56e-06	0.000171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—prostate cancer	5.43e-06	0.000167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPL—prostate cancer	5.38e-06	0.000165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAV1—prostate cancer	5.34e-06	0.000164	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFRB—prostate cancer	5.33e-06	0.000164	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CB—prostate cancer	5.28e-06	0.000162	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ITGB3—prostate cancer	5.2e-06	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARA—prostate cancer	5.17e-06	0.000159	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.11e-06	0.000157	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—prostate cancer	5.07e-06	0.000156	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	5.06e-06	0.000156	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB3—prostate cancer	5.04e-06	0.000155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGFR2—prostate cancer	5.03e-06	0.000155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CG—prostate cancer	4.87e-06	0.00015	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2—prostate cancer	4.85e-06	0.000149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TERT—prostate cancer	4.83e-06	0.000148	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR1—prostate cancer	4.69e-06	0.000144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HIF1A—prostate cancer	4.62e-06	0.000142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—INS—prostate cancer	4.61e-06	0.000142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—prostate cancer	4.58e-06	0.000141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CREBBP—prostate cancer	4.51e-06	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—prostate cancer	4.51e-06	0.000139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CAV1—prostate cancer	4.47e-06	0.000137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KDR—prostate cancer	4.42e-06	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ESR1—prostate cancer	4.31e-06	0.000132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CD—prostate cancer	4.28e-06	0.000132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BAD—prostate cancer	4.2e-06	0.000129	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CREBBP—prostate cancer	4.11e-06	0.000126	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APC—prostate cancer	4.07e-06	0.000125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CG—prostate cancer	4.07e-06	0.000125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—prostate cancer	4.04e-06	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGF—prostate cancer	4.02e-06	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IRS1—prostate cancer	4.02e-06	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GSK3B—prostate cancer	3.91e-06	0.00012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INS—prostate cancer	3.85e-06	0.000118	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—prostate cancer	3.85e-06	0.000118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CREBBP—prostate cancer	3.77e-06	0.000116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CB—prostate cancer	3.73e-06	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—prostate cancer	3.73e-06	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—prostate cancer	3.71e-06	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—prostate cancer	3.7e-06	0.000114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAP2K1—prostate cancer	3.6e-06	0.000111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CD—prostate cancer	3.58e-06	0.00011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—prostate cancer	3.54e-06	0.000109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KRAS—prostate cancer	3.5e-06	0.000108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF2—prostate cancer	3.43e-06	0.000105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—prostate cancer	3.38e-06	0.000104	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JAK2—prostate cancer	3.28e-06	0.000101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—prostate cancer	3.22e-06	9.91e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—prostate cancer	3.22e-06	9.89e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MDM2—prostate cancer	3.21e-06	9.85e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ERBB2—prostate cancer	3.16e-06	9.71e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CB—prostate cancer	3.12e-06	9.59e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—EP300—prostate cancer	3.07e-06	9.45e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—prostate cancer	3e-06	9.21e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—prostate cancer	2.93e-06	9e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—prostate cancer	2.87e-06	8.82e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2—prostate cancer	2.86e-06	8.8e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—prostate cancer	2.85e-06	8.76e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—prostate cancer	2.79e-06	8.58e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CTNNB1—prostate cancer	2.77e-06	8.5e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—prostate cancer	2.71e-06	8.33e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1A—prostate cancer	2.7e-06	8.3e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—prostate cancer	2.7e-06	8.28e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—prostate cancer	2.63e-06	8.08e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EP300—prostate cancer	2.57e-06	7.9e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SRC—prostate cancer	2.5e-06	7.68e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—prostate cancer	2.44e-06	7.49e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—prostate cancer	2.43e-06	7.48e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—prostate cancer	2.41e-06	7.41e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—prostate cancer	2.27e-06	6.99e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—prostate cancer	2.24e-06	6.88e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—prostate cancer	2.23e-06	6.87e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—prostate cancer	2.19e-06	6.73e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KRAS—prostate cancer	2.07e-06	6.36e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—prostate cancer	1.9e-06	5.84e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—prostate cancer	1.86e-06	5.71e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—prostate cancer	1.84e-06	5.65e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—prostate cancer	1.69e-06	5.19e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—prostate cancer	1.68e-06	5.17e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—prostate cancer	1.55e-06	4.77e-05	CbGpPWpGaD
